Bidirectional epigenetic editing reveals hierarchies in gene regulation

Nat Biotechnol. 2025 Mar;43(3):355-368. doi: 10.1038/s41587-024-02213-3. Epub 2024 May 17.

Abstract

CRISPR perturbation methods are limited in their ability to study non-coding elements and genetic interactions. In this study, we developed a system for bidirectional epigenetic editing, called CRISPRai, in which we apply activating (CRISPRa) and repressive (CRISPRi) perturbations to two loci simultaneously in the same cell. We developed CRISPRai Perturb-seq by coupling dual perturbation gRNA detection with single-cell RNA sequencing, enabling study of pooled perturbations in a mixed single-cell population. We applied this platform to study the genetic interaction between two hematopoietic lineage transcription factors, SPI1 and GATA1, and discovered novel characteristics of their co-regulation on downstream target genes, including differences in SPI1 and GATA1 occupancy at genes that are regulated through different modes. We also studied the regulatory landscape of IL2 (interleukin-2) in Jurkat T cells, primary T cells and chimeric antigen receptor (CAR) T cells and elucidated mechanisms of enhancer-mediated IL2 gene regulation. CRISPRai facilitates investigation of context-specific genetic interactions, provides new insights into gene regulation and will enable exploration of non-coding disease-associated variants.

MeSH terms

  • CRISPR-Cas Systems / genetics
  • Epigenesis, Genetic* / genetics
  • Epigenome Editing
  • GATA1 Transcription Factor / genetics
  • Gene Editing* / methods
  • Gene Expression Regulation* / genetics
  • Humans
  • Interleukin-2 / genetics
  • Jurkat Cells
  • Proto-Oncogene Protein Spi-1
  • Proto-Oncogene Proteins / genetics
  • Single-Cell Analysis
  • T-Lymphocytes / metabolism
  • Trans-Activators

Substances

  • GATA1 Transcription Factor
  • Interleukin-2
  • Proto-Oncogene Proteins
  • Trans-Activators
  • Proto-Oncogene Protein Spi-1
  • GATA1 protein, human